Gene Amplification Technologies Market by Technology (Signal Amplification, Next Generation Sequencing, Target Amplification, Cycling Temperature DNA Amplification, Isothermal Signal Amplification, Isothermal DNA Amplification, Linear Gene Amplification, Exponential Gene Amplification, and Cycling Temperature Signal Gene Amplification), Applications (Forensics Application, Medical Application, Personnel Identification, Paternity, Agri-diagnostics, Veterinary, and Food Safety), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

The global gene amplification technologies market size is estimated to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising demand for genetic information for the purpose of identifying & planning all the genes of the human genome. Moreover, increasing R&D programs in numerous fields such as forensics, molecular diagnostics, genetic testing, drug discovery, biological research, environmental monitoring, toxicology, bioremediation, animal husbandry, and quality control in the food industry present major aspect for the market expansion.

Gene amplification is one of the most essential technologies utilized in genomic projects and also plays a key role in other areas including diagnostics. From polymerase chain reaction (PCR) to ligase chain reaction, dendritic polymers and transcription mediated amplification, a plethora of gene and signal amplification technologies are adopted. Moreover, PCR is the most widely used technology for gene amplification. It is one of the most effective tools for gene amplification, which allows researchers to achieve millions of copies of a gene in a short period of time. Furthermore, alternatives and innovative & advanced technologies such as rolling circle amplification, loop mediated isothermal amplification, self-sustained sequence replication, and nucleic acid sequence based amplification, are expected to propel the market growth.

The outbreak of COVID-19 pandemic has affected the market as it forced to shut the production units globally. Moreover, low demand for instruments and consumables along with the global supply chain interruptions and trade restrictions have harmed the market for months. However, due to wide application of the PCR methods for the COVID patients, the market revenue is rising at a significant pace.

Market Trends, Drivers, Restraints, and Opportunities

• Increasing technological advancement such as molecular services and next generation sequencing (NGS) are expected to boost the market growth.
• Rising government funding & grants towards genomics and growing customized medicine are key factors propelling the market growth.
• Increased efficacy in operations, technical expertise, and on demand service for analytical testing devices are fueling the market expansion.
• Inadequacy of skilled personnel for handling the testing devices and high cost of instruments are major restraining factors expected to hamper the market growth.
• Ongoing development operational expertise by key pharmaceutical players to enhance the laboratory testing are likely to offer immense opportunities for the market development in the long run.

Scope of the Report

The report on the global gene amplification technologies market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Next generation sequencing segment is expected to grow at a rapid pace

Based on technology, the global gene amplification technologies market is segmented into signal amplification, next generation sequencing (NGS), target amplification, cycling temperature DNA amplification, isothermal signal amplification, isothermal DNA amplification, linear gene amplification, exponential gene amplification, and cycling temperature signal gene amplification. The NGS segment is expected to grow at a rapid pace during the forecast period owing to the cost- effective, high efficacy & accuracy even from low sample input. Moreover, the technology is presently used in the detection of cancer, hematological disorders, psychiatry, pharmacogenomics, neurology, dysmorphology, visual & hearing impairment, and cardiology among other diseases. Thus, aforementioned factors are propelling the segment growth.

Food safety segment is projected to expand at a considerable CAGR

On the basis of applications, the market is segregated as forensics application, medical application, personnel identification, paternity, agri-diagnostics, veterinary, and food safety. The food safety segment is projected to expand at a considerable CAGR during the forecast period. In both industrialized and developing countries, foodborne infections are becoming a serious public health concern. Changing business needs as a result of regulations as well as rising food consumption patterns are fueling the demand for improved and faster food safety diagnostics. Furthermore, the food safety testing technologies are rapidly used for screening methods such as ELISA-based approaches, PCR IMS, and immunoassay, as well as classic methods such as culture enrichment and selective agar method. Thus, these factors are fueling the segment growth in coming years.

North America is anticipated to constitute a key market share

In terms of regions, the global gene amplification technologies market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to the growing investments in healthcare infrastructures, technological innovation, availability of government funds, focusing on research in the fields of diagnostics, detection of critical diseases, and genetic testing in the region.

However, the market of Asia Pacific is projected to register a considerable growth in the coming years. The growth of the market in the region attributed to the increasing focus on improving healthcare infrastructure, rising highly skilled employees for conducting research, lower costs, and government assistance in the region.

Segments

The global gene amplification technologies market has been segmented on the basis of

Technology

• Signal Amplification
• Next Generation Sequencing
• Target Amplification
• Cycling Temperature DNA Amplification
• Isothermal Signal Amplification
• Isothermal DNA Amplification
• Linear Gene Amplification
• Exponential Gene Amplification
• Cycling Temperature Signal Gene Amplification

Applications

• Forensics Application
• Medical Application
• Personnel Identification
• Paternity
• Agri-diagnostics
• Veterinary
• Food Safety

Regions

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Takara Bio, Inc.
• Abbott Laboratories
• Agilent Technologies Inc.
• QIAGEN N.V.
• Rubicon Genomics
• Bayer Corp.
• Roche Diagnostics
• bioMérieux
• Bio-Rad Laboratories
• Cepheid
• Life Technologies Corp.
• Becton, Dickinson and Co.

Competitive Landscape

Some of the major players competing in the global gene amplification technologies market are Takara Bio, Inc.; Abbott Laboratories; Agilent Technologies Inc.; QIAGEN N.V.; Rubicon Genomics; Bayer Corp.; Roche Diagnostics; bioMérieux; Bio-Rad Laboratories; Cepheid; Life Technologies Corp.; and Becton, Dickinson and Co.

Most of these companies are focusing on R&D activities to come up with innovative and advanced technology in gene amplification, as well as implementing other strategic move, such as merger & acquisition, partnerships & collaboration in order to gain larger market share in the long run.